ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05340	Primary immunodeficiency	3/20	30/7206	7.07795638808e-05
ko04064	NF-kappa B signaling pathway	4/20	96/7206	0.000121696902381
ko05321	Inflammatory bowel disease (IBD)	3/20	56/7206	0.000461505762151
ko04621	NOD-like receptor signaling pathway	4/20	157/7206	0.000800208106932
ko05310	Asthma	2/20	17/7206	0.000970827083779
ko04217	Necroptosis	4/20	178/7206	0.00127922560323
ko05167	Kaposi's sarcoma-associated herpesvirus infection	4/20	191/7206	0.00166073119633
ko05330	Allograft rejection	2/20	24/7206	0.00194739271856
ko04658	Th1 and Th2 cell differentiation	3/20	96/7206	0.00221616300417
ko05320	Autoimmune thyroid disease	2/20	29/7206	0.00284092394389
ko04659	Th17 cell differentiation	3/20	106/7206	0.00293982786246
ko05162	Measles	3/20	120/7206	0.00417489825782
ko04672	Intestinal immune network for IgA production	2/20	37/7206	0.00459869363023
ko05145	Toxoplasmosis	3/20	126/7206	0.0047877149117
ko04933	AGE-RAGE signaling pathway in diabetic complications	3/20	135/7206	0.00580500687732
ko05144	Malaria	2/20	45/7206	0.0067457028101
ko05160	Hepatitis C	3/20	153/7206	0.00820731532833
ko05416	Viral myocarditis	2/20	55/7206	0.00995211540055
ko05161	Hepatitis B	3/20	173/7206	0.0114790682961
ko04060	Cytokine-cytokine receptor interaction	3/20	191/7206	0.0149890082045
ko05140	Leishmaniasis	2/20	75/7206	0.0179916240781
ko05169	Epstein-Barr virus infection	3/20	206/7206	0.0183345465322
ko04917	Prolactin signaling pathway	2/20	87/7206	0.0237783742812
ko04662	B cell receptor signaling pathway	2/20	88/7206	0.0242912120657
ko04620	Toll-like receptor signaling pathway	2/20	100/7206	0.0307951836053
ko05203	Viral carcinogenesis	3/20	277/7206	0.0394773952809
ko05166	HTLV-I infection	3/20	292/7206	0.0450635279893
ko04660	T cell receptor signaling pathway	2/20	124/7206	0.0456050186367
ko04514	Cell adhesion molecules (CAMs)	2/20	130/7206	0.0496519635469